Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction

BACKGROUND: Receptor-interacting protein kinase 2 (RIPK2, also known as RIP2) was reported to be associated with bacterial infections as well as inflammatory responses. However, the role of RIPK2 in prognosis and immunotherapy response is yet to be elucidated in human pan-cancer. METHODS: In this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Junquan, Yang, Runyu, Wei, Rongyuan, Du, Yue, He, Pengcheng, Liu, Xiaowen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066895/
https://www.ncbi.nlm.nih.gov/pubmed/35508972
http://dx.doi.org/10.1186/s10020-022-00475-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066895/
https://www.ncbi.nlm.nih.gov/pubmed/35508972
http://dx.doi.org/10.1186/s10020-022-00475-8

Ejemplares similares